Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Catheter Precision (VTAK) Other Operating Expenses (2022 - 2025)

Catheter Precision has reported Other Operating Expenses over the past 4 years, most recently at $7.0 million for Q4 2025.

  • Quarterly Other Operating Expenses changed N/A to $7.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $9.0 million through Dec 2025, up 417.46% year-over-year, with the annual reading at $9.0 million for FY2025, N/A changed from the prior year.
  • Other Operating Expenses was $7.0 million for Q4 2025 at Catheter Precision, up from $1.8 million in the prior quarter.
  • Over five years, Other Operating Expenses peaked at $7.0 million in Q4 2025 and troughed at -$76.4 million in Q4 2023.
  • The 4-year median for Other Operating Expenses is $119000.0 (2025), against an average of -$4.6 million.
  • Year-over-year, Other Operating Expenses crashed 74236.89% in 2023 and then soared 301.69% in 2025.
  • A 4-year view of Other Operating Expenses shows it stood at $103000.0 in 2022, then crashed by 74236.89% to -$76.4 million in 2023, then soared by 98.35% to -$1.3 million in 2024, then soared by 654.72% to $7.0 million in 2025.
  • Per Business Quant, the three most recent readings for VTAK's Other Operating Expenses are $7.0 million (Q4 2025), $1.8 million (Q2 2025), and $119000.0 (Q1 2025).